CEO Dave Mehalick discusses Copeits Therapeutics leading presence in cellular engineering and their push into the oncology space.
March 15, 2023
January 16, 2023
May 25, 2022
March 30, 2022
We use cookies to improve your experience on our site, to show you personalized advertising, and as otherwise described in our Cookie Policy . To find out more, read our Privacy Policy and our Cookie Policy.
